Firebrick Pharma Limited (ASX: FRE)
Australia
· Delayed Price · Currency is AUD
0.0560
+0.0020 (3.70%)
Dec 20, 2024, 3:45 PM AEST
Firebrick Pharma Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Operating Revenue | 0.01 | 0.01 | 0 | 0 | - | - |
| Other Revenue | 2.74 | 2.74 | 0.02 | 1.08 | 0.42 | 0.51 |
| Revenue | 2.75 | 2.75 | 0.02 | 1.08 | 0.42 | 0.51 |
| Revenue Growth (YoY) | 12096.48% | 12096.48% | -97.92% | 156.72% | -17.09% | - |
| Cost of Revenue | 0.04 | 0.04 | - | - | - | - |
| Gross Profit | 2.71 | 2.71 | 0.02 | 1.08 | 0.42 | 0.51 |
| Selling, General & Admin | 1.75 | 1.75 | 2.48 | 1.92 | 1.12 | 0.07 |
| Research & Development | 1.91 | 1.91 | 4.09 | 2.22 | 1.13 | 1.63 |
| Other Operating Expenses | 0.14 | 0.14 | 0.19 | 0.14 | 0.07 | - |
| Operating Expenses | 3.8 | 3.8 | 6.77 | 4.59 | 2.86 | 2.01 |
| Operating Income | -1.09 | -1.09 | -6.75 | -3.51 | -2.44 | -1.5 |
| Interest Expense | -0 | -0 | - | -0 | - | - |
| Interest & Investment Income | 0.02 | 0.02 | 0.04 | 0 | 0 | 0 |
| Other Non Operating Income (Expenses) | -0.1 | -0.1 | -0.09 | -0.28 | - | - |
| Pretax Income | -1.18 | -1.18 | -6.8 | -3.8 | -2.44 | -1.5 |
| Net Income | -1.18 | -1.18 | -6.8 | -3.8 | -2.44 | -1.5 |
| Net Income to Common | -1.18 | -1.18 | -6.8 | -3.8 | -2.44 | -1.5 |
| Shares Outstanding (Basic) | 179 | 179 | 170 | 117 | 111 | 30 |
| Shares Outstanding (Diluted) | 179 | 179 | 170 | 117 | 111 | 30 |
| Shares Change (YoY) | 5.25% | 5.25% | 45.98% | 5.45% | 265.19% | - |
| EPS (Basic) | -0.01 | -0.01 | -0.04 | -0.03 | -0.02 | -0.05 |
| EPS (Diluted) | -0.01 | -0.01 | -0.04 | -0.03 | -0.02 | -0.05 |
| Free Cash Flow | -2.35 | -2.35 | -5.78 | -4.23 | -1.95 | -0.99 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.04 | -0.02 | -0.03 |
| Gross Margin | 98.64% | 98.64% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -39.70% | -39.70% | -29941.76% | -323.93% | -578.15% | -294.51% |
| Profit Margin | -42.75% | -42.75% | -30164.40% | -350.42% | -577.97% | -294.41% |
| Free Cash Flow Margin | -85.26% | -85.26% | -25653.98% | -390.90% | -462.60% | -193.53% |
| EBITDA | -1.08 | -1.08 | -6.74 | -3.5 | -2.44 | -1.5 |
| EBITDA Margin | -39.44% | -39.44% | - | - | - | -294.45% |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| EBIT | -1.09 | -1.09 | -6.75 | -3.51 | -2.44 | -1.5 |
| EBIT Margin | -39.70% | -39.70% | - | - | - | -294.51% |
Source: S&P Capital IQ. Standard template.
Financial Sources.